IMMX 8-K 2026-09-30
Immix Biopharma, Inc. (IMMX) 8-K dated 2026-09-30 — accession 0001493152-26-045143.
Immix Biopharma, Inc. (IMMX) is a biotechnology company listed on US.
Immix Biopharma, Inc. filed a 8-K on 2026-09-30. Accession 0001493152-26-045143.
This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported IMMX revenue for 2022-12-08 was $20.0M. IMMX currently screens at market cap $640.7M.
Not investment advice. The IMMX SEC hub lists recent forms. The stock page is the research view.